These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33506961)

  • 1. Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis.
    Lambrichts S; Detraux J; Vansteelandt K; Nordenskjöld A; Obbels J; Schrijvers D; Sienaert P
    Acta Psychiatr Scand; 2021 Apr; 143(4):294-306. PubMed ID: 33506961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA; Haskett RF; Mulsant BH; Thase ME; Mann JJ; Pettinati HM; Greenberg RM; Crowe RR; Cooper TB; Prudic J
    JAMA; 2001 Mar; 285(10):1299-307. PubMed ID: 11255384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis.
    Jelovac A; Kolshus E; McLoughlin DM
    Neuropsychopharmacology; 2013 Nov; 38(12):2467-74. PubMed ID: 23774532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A; von Knorring L; Ljung T; Carlborg A; Brus O; Engström I
    J ECT; 2013 Jun; 29(2):86-92. PubMed ID: 23303421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses.
    Elias A; Phutane VH; Clarke S; Prudic J
    Aust N Z J Psychiatry; 2018 May; 52(5):415-424. PubMed ID: 29256252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse following bitemporal and high-dose right unilateral electroconvulsive therapy for major depression.
    Jelovac A; Kolshus E; McLoughlin DM
    Acta Psychiatr Scand; 2021 Sep; 144(3):218-229. PubMed ID: 34033117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
    Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
    Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of Continuation or Maintenance Electroconvulsive Therapy Caused by the COVID-19 Pandemic: A Naturalistic Study Investigating Relapse in Patients With Major Depressive Disorder.
    Van de Velde N; Geerts PJ; Tandt H; Vanderhasselt MA; Titeca K; Lemmens G
    J ECT; 2021 Dec; 37(4):230-237. PubMed ID: 34145171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.
    McCall WV; Lisanby SH; Rosenquist PB; Dooley M; Husain MM; Knapp RG; Petrides G; Rudorfer MV; Young RC; McClintock SM; Mueller M; Prudic J; Greenberg RM; Weiner RD; Bailine SH; Youssef NA; McCloud L; Kellner CH;
    J Psychiatr Res; 2018 Feb; 97():65-69. PubMed ID: 29195125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.
    Greenhalgh J; Knight C; Hind D; Beverley C; Walters S
    Health Technol Assess; 2005 Mar; 9(9):1-156, iii-iv. PubMed ID: 15774232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?
    Lambrichts S; Vansteelandt K; Hebbrecht K; Wagenmakers MJ; Oudega ML; Obbels J; van Exel E; Dols A; Bouckaert F; Schrijvers D; Verwijk E; Sienaert P
    J Psychiatr Res; 2022 Oct; 154():111-116. PubMed ID: 35933854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression.
    Itagaki K; Takebayashi M; Shibasaki C; Kajitani N; Abe H; Okada-Tsuchioka M; Yamawaki S
    J Affect Disord; 2017 Jan; 208():113-119. PubMed ID: 27764738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Electroconvulsive Therapy for Preventing Relapse and Recurrence of Depression in Adults With Major Depressive Disorder: An Updated Meta-Analysis of Randomized Clinical Trials.
    Dar H; Vuthaluru K; Folajimi A; Maheshwari L; Shah J; Senaratne M; Pizzorno G; Ali N
    Cureus; 2023 Mar; 15(3):e35683. PubMed ID: 37012942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy.
    Shapira B; Gorfine M; Lerer B
    Convuls Ther; 1995 Jun; 11(2):80-5. PubMed ID: 7552058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    McCall WV; Rosenquist PB; Kimball J; Haskett R; Isenberg K; Prudic J; Lasater B; Sackeim HA
    J ECT; 2011 Jun; 27(2):97-102. PubMed ID: 21206285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression.
    Pluijms EM; Vinther PT; Kamperman AM; Birkenhäger TK
    Acta Psychiatr Scand; 2023 Jun; 147(6):561-569. PubMed ID: 36938869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.
    Youssef NA; McCall WV
    Ann Clin Psychiatry; 2014 Nov; 26(4):288-96. PubMed ID: 25401716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients.
    Gagné GG; Furman MJ; Carpenter LL; Price LH
    Am J Psychiatry; 2000 Dec; 157(12):1960-5. PubMed ID: 11097961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.